Phase 2 Alzheimer Disease (AD) Clinical Trials

2 recruitingPhase 2

What is a Phase 2 trial?

Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.

Showing 1–2 of 2 trials

Recruiting

Phase 2

Daridorexant for Alzheimer Disease Prevention

Alzheimer Disease (AD)

Douglas Mental Health University Institute240 enrolled1 locationNCT07213349

Recruiting

Phase 1Phase 2

Safety, PK and Biodistribution of 18F-OP-801 in Patients With ALS, AD, MS, PD and Healthy Volunteers

Amyotrophic Lateral Sclerosis(ALS)Alzheimer Disease (AD)Parkinson Disease (PD)+1 more

Ashvattha Therapeutics, Inc.65 enrolled3 locationsNCT05395624